Results 221 to 230 of about 823,307 (385)

Defining conversion therapy for esophageal squamous cell carcinoma

Annals of Gastroenterological Surgery, Volume 7, Issue 1, Page 7-9, January 2023., 2023
A multimodality treatment conference with experts from across East Asia was held to establish a consensus for conversion therapy. An agreement was reached that conversion therapy was defined as surgery or chemoradiotherapy (CRT) aiming at cure after initial treatment for tumors that were initially unresectable due to adjacent organ invasion or distant ...
Satoru Matsuda, Takahiro Tsushima, Ken Kato, Chih‐Hung Hsu, Jang Ming Lee, Ian Yu‐Hong Wong, Hu‐Lin Christina Wang, Chang Hyun Kang, Xufeng Guo, Shun Yamamoto, Takayuki Tsuji, Hirofumi Kawakubo, Hiroya Takeuchi, Simon Law, Yuko Kitagawa   +14 more
wiley   +1 more source

Metachronous gastro-oesophageal adenocarcinoma in a patient with colon adenocarcinoma. [PDF]

BMJ Case Rep
Meseeha M, Dudhat S, Sehrish L, Attia M.
europepmc   +1 more source

Anti-tumour efficacy of calusterone against DMBA-induced rat mammary adenocarcinoma in vivo and in organ culture [PDF]

, 1976
H. Horn, Ira Erlichman, I.S. Levij
openalex   +1 more source

TRIM38 Suppresses the Progression of Colorectal Cancer via Enhancing CCT6A Ubiquitination to Inhibit the MYC Pathway

Advanced Science, EarlyView.
This study reveals the tumor‐suppressive role of TRIM38 in colorectal cancer (CRC). TRIM38 is downregulated through DNA hypermethylation and correlates with unfavorable clinical features and poor prognosis. Mechanistically, TRIM38 inhibits CRC progression by promoting K48‐linked ubiquitination of CCT6A, leading to the destabilization of c‐Myc.
Yue Zhang, Xinyu Tan, Lu Wang, Dongjian Ji, Chuan Zhang, Wen Peng, Renzhong Zhu, Xiaowei Wang, Jiahui Zhou, Yifei Feng, Yueming Sun   +10 more
wiley   +1 more source

Double the trouble: pulmonary enteric adenocarcinoma with synchronous contralateral pulmonary adenocarcinoma. [PDF]

Oxf Med Case Reports
Yuan K, Van Dellen MM, Fenderson JL.
europepmc   +1 more source

Caspase‐6/Gasdermin C‐Mediated Tumor Cell Pyroptosis Promotes Colorectal Cancer Progression Through CXCL2‐Dependent Recruitment of Myeloid‐Derived Suppressor Cells

Advanced Science, EarlyView.
Hypoxic and low‐glucose conditions in tumor tissues trigger colorectal tumor cell pyroptosis via sequential activation of the Caspase‐1/Caspase‐6/GSDMC axis. High mobility group box 1 (HMGB1), released from GSDMC‐mediated pyroptotic tumor cells, upregulates CXCL2 expression in adjacent tumor cells, thereby recruiting myeloid‐derived suppressor cells ...
Hanchao Gao, Yikun Yao, Weilong Li, Zigan Xu, Wenjun Hu, Kewang Luo, Peishan Chen, Wanjing Shang, Shaodong Luan, Guojun Shi, Mengtao Cao, Pengfei Chen   +11 more
wiley   +1 more source

Genomic features of liquid biopsies from patients with prostate cancer with and without ductal adenocarcinoma. [PDF]

J Pathol Clin Res
Zhu Q, Wang T, Shi Y, Zhou X, Liu D, Chen J, Liu H, Zhao F, Xu C, Chen Y, Liang J, Chen N, Shen P, Zeng H, Zhao J.   +14 more
europepmc   +1 more source

Primary Adenocarcinoma of the Lung in Men

, 1968
William F. Sasser, Dale E. Bennett, T. Bruce Ferguson, Thomas H. Burford   +3 more
openalex   +1 more source

An oviduct adenocarcinoma in a mauritius kestrel (Falco punctatus) [PDF]

, 1979
J. E. Cooper
openalex   +1 more source

The Novel Dual GIP and GLP‐1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism

Advanced Science, EarlyView.
Tirzepatide, a dual GIP/GLP‐1 receptor agonist for diabetes, suppresses colorectal cancer growth by targeting glucose metabolism. It inhibits cancer cell proliferation, promotes apoptosis, and induces tumor regression. It reduces glucose uptake and destabilizes HIF‐1α for degradation to downregulate PFKFB3/PFK‐1 enzymes, thus contributing to the ...
Yikai Zhang, Yi Xie, Shenglong Xia, Xinnuo Ge, Jiaying Li, Fang Liu, Fan Jia, Shengyao Wang, Qiao Zhou, Menghan Gao, Weihuan Fang, Chao Zheng   +11 more
wiley   +1 more source